Table 3.
Leptin and brain tumors: mechanistic observations
| Tumor/Cell type | Investigated factor | Mechanism | Outcome | Ref. |
|---|---|---|---|---|
| Cultured GH-secreting human pituitary adenoma cells | Leptin priming | Spontaneous GH discharge reduced | Low GH levels in obesity | [90] |
| GHRH-induced discharge increased | Low GHRH-induced GH in obesity | |||
| Glioblastoma cells | OB-Rb expression | STAT3, SOX2/OCT signaling axis |
Invasiveness and proliferation ↓ temozolide resistance |
[93] |
| Glioblastoma tumors | Resection and recurrence | Percentage of OB-Rb+ cells increased | Increased malignancy and self-renewal | [93] |
| OB-Rb+ tumors in nude mice | Leptin treatment | (Not specified) | Increased tumor volume | [93] |
| Glioma stem-like cells (CD133+) | Leptin treatment |
JAK/STAT3 signaling pathway ↓ Increased MMP9, β-integrin, N-cadherin, and vimentin expression |
Increased invasive ability | [94] |